Biologic Tapering in axSpA: What Research Says and What it Means for Patients

Spondycast by The Spondylitis Association of America (SAA)

S03 E22
31:49
Episode notes

Rheumatologist Dr. Marina Magrey discusses her latest research on biologic DMARD dose tapering in axial spondyloarthritis, outlining when it may be appropriate, its risks and benefits, and key considerations for patients.

Keywords
researchmedicationflaresbiologic taperingTNF Inhibitors